The AHA’s Health Research & Educational Trust affiliate and the Centers for Disease Control and Prevention today announced a three-year initiative to improve the implementation of infection prevention and control efforts in U.S. hospitals. The project will work with state hospital associations, state health departments, the Centers for Medicare & Medicaid Services’ Quality Improvement Networks, AHA’s American Society for Healthcare Engineering affiliate and other partners to reduce central line-associated bloodstream infections, catheter-associated urinary tract infections, Clostridium difficile infections and methicillin-resistant Staphylococcus aureus infections in targeted acute care hospitals. “We welcome the opportunity to work with CDC on the important issue of infection prevention,” said Maulik Joshi, president of HRET and associate executive vice president of AHA. “This project will build on our national work that has successfully reduced CAUTI and CLABSI rates and improved patient care.”

Headline
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge,…
Headline
Stormee Williams, M.D., senior vice president and chief health equity officer at Children’s Health, shares how her team is identifying food insecurity, why…
Headline
President Trump signed an executive order May 29 that directs the Centers for Disease Control and Prevention and the Advisory Committee on Immunization…